NOVOZYMES A/S: Financial statements 2022
CVR: 10007127
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
NOVOZYMES A/S (CVR 10007127) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 17,553,000,000 and a net result of DKK 3,686,000,000 compared with DKK 3,145,000,000 the year before. That is an increase of 17.4% compared with the year before. The profit margin was 21%. Equity in the 2022 report amounted to DKK 14,228,000,000. The solvency ratio was 50.8%. The company had 6,690 employees in the financial year.
- Revenue
- DKK 17,553,000,000
- Gross Profit
- DKK 9,577,000,000
- Profit/Loss
- DKK 3,686,000,000
- Equity
- DKK 14,228,000,000
- Total Assets
- DKK 27,983,000,000
- Employees
- 6,690
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 17.6B | 9.6B | 3.7B | 14.2B | 6690 |
| 2021 | 15B | 8.6B | 3.1B | 12.2B | 6240 |
| 2020 | 14B | 7.9B | 2.8B | 11.2B | 6099 |
| 2019 | 14.4B | 8B | 3.2B | 11.5B | - |
| 2018 | 14.4B | 8.3B | 3.2B | 11.4B | - |
Official annual report
Keep an eye on NOVOZYMES A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
NOVOZYMES A/S has published its interim report for the period January 1, 2022 to September 30, 2022.
NOVOZYMES A/S has published its interim report for the period January 1, 2022 to June 30, 2022.
NOVOZYMES A/S has published its annual report for 2021. Revenue came to DKK 14,951,000,000, and the net result was DKK 3,145,000,000.
NOVOZYMES A/S has published its interim report for the period January 1, 2022 to March 31, 2022.
As of March 16, 2022, Morten Otto Alexander Sommer has joined the board of directors of NOVOZYMES A/S.
As of March 16, 2022, Carl Erik Mathias Uhlén has left the board of directors of NOVOZYMES A/S.
About NOVOZYMES A/S
NOVOZYMES A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2000. The company is registered under the industry Fremstilling af andre organiske basiskemikalier. The management consists of Ester Baiget Arnau and Rainer Chapour Lehmann. The board consists of Cornelis de Jong (chair), Heine Dalsgaard, Frederikke Rose Spenner and Kasim Kutay. The company is owned by Novo Holdings A/S and BlackRock, Inc.. The company has 3,508 employees (2026). In 2025, the company reported revenue of EUR 4,157,600,000 and a net result of EUR 583,600,000 compared with EUR 305,800,000 the year before. Equity in the 2025 report amounted to EUR 10,855,200,000.